oral mucositis Oragenics AG013
Oragenics resumes Phase ll trial of AG013 for oral mucositis
Oragenics has resumed its Phase ll clinical trial of AG013 for the treatment of oral mucositis (OM), after a positive…
Oragenics has resumed its Phase ll clinical trial of AG013 for the treatment of oral mucositis (OM), after a positive…